ReviewCureus2024

Compare the Efficacy and Safety of Deferoxamine, Deferasirox, and Deferiprone in Patients With Sickle Cell Disease or Transfusion-Dependent Anemia: A Network Meta-Analysis of Randomized Control Trials.

Divine Besong Arrey Agbor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.